Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium.
Nasreddine R, Florence E, Yombi JC, Henrard S, Darcis G, Van Praet J, Vandekerckhove L, Allard SD, Demeester R, Messiaen P, Ausselet N, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH). Nasreddine R, et al. Among authors: messiaen p. HIV Med. 2023 Aug;24(8):914-924. doi: 10.1111/hiv.13493. Epub 2023 Apr 10. HIV Med. 2023. PMID: 37038245 Free article.
The impact of nevirapine- versus protease inhibitor-based regimens on virological markers of HIV-1 persistence during seemingly suppressive ART.
Kiselinova M, Anna M, Malatinkova E, Vervish K, Beloukas A, Messiaen P, Bonczkowski P, Trypsteen W, Callens S, Verhofstede C, De Spiegelaere W, Vandekerckhove L. Kiselinova M, et al. Among authors: messiaen p. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19823. doi: 10.7448/IAS.17.4.19823. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397567 Free PMC article.
Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
Nasreddine R, Florence E, Moutschen M, Yombi JC, Goffard JC, Derdelinckx I, Lacor P, Vandekerckhove L, Messiaen P, Vandecasteele S, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH). Nasreddine R, et al. Among authors: messiaen p. J Med Virol. 2021 May;93(5):2971-2978. doi: 10.1002/jmv.26828. Epub 2021 Feb 9. J Med Virol. 2021. PMID: 33506953 Free PMC article.
A public health value-based healthcare paradigm for HIV.
Vermeersch S, Demeester RP, Ausselet N, Callens S, De Munter P, Florence E, Goffard JC, Henrard S, Lacor P, Messiaen P, Libois A, Seyler L, Uurlings F, Vandecasteele SJ, Van Wijngaerden E, Yombi JC, Annemans L, De Wit S. Vermeersch S, et al. Among authors: messiaen p. BMC Health Serv Res. 2022 Jan 2;22(1):13. doi: 10.1186/s12913-021-07371-7. BMC Health Serv Res. 2022. PMID: 34974833 Free PMC article.
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium.
Nasreddine R, Yombi JC, Darcis G, Florence E, Allard SD, De Scheerder MA, Henrard S, Demeester R, Messiaen P, Ausselet N, Loeckx M, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH). Nasreddine R, et al. Among authors: messiaen p. HIV Med. 2023 Mar;24(3):267-278. doi: 10.1111/hiv.13373. Epub 2022 Aug 8. HIV Med. 2023. PMID: 35938381
45 results